Gilead Sciences
GILD
Gilead Sciences (GILD) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Needham | Maintained | Buy | $170.00 | Aug 5, 2026 |
| Cantor Fitzgerald | Maintained | Overweight | $155.00 | Aug 5, 2026 |
| RBC Capital | Maintained | Sector Perform | $123.00 from $120.00 | Aug 5, 2026 |
| Barclays | Maintained | Equal-Weight | $145.00 from $155.00 | Jul 29, 2026 |
| Morgan Stanley | Maintained | Overweight | $165.00 from $166.00 | Jul 27, 2026 |
| Leerink Partners | Downgraded | Outperform → Market Perform | $127.00 from $146.00 | Jul 21, 2026 |
| Morgan Stanley | Maintained | Overweight | $166.00 from $168.00 | Jul 8, 2026 |
| Truist Securities | Maintained | Buy | $156.00 from $157.00 | Jul 7, 2026 |
| RBC Capital | Maintained | Sector Perform | $120.00 from $122.00 | Jul 7, 2026 |
| HSBC | Upgraded | Hold → Buy | $155.00 from $133.00 | Jul 6, 2026 |
| Cantor Fitzgerald | Maintained | Overweight | $155.00 | Jul 6, 2026 |
| Cantor Fitzgerald | Maintained | Overweight | $155.00 | Jun 16, 2026 |
| Maxim Group | Upgraded | Hold → Buy | $165.00 | May 20, 2026 |
| Truist Securities | Maintained | Buy | $157.00 from $155.00 | May 8, 2026 |
| RBC Capital | Maintained | Sector Perform | $122.00 from $123.00 | May 8, 2026 |
| Citigroup | Maintained | Buy | $165.00 from $156.00 | Apr 13, 2026 |
| Morgan Stanley | Maintained | Overweight | $175.00 from $171.00 | Apr 10, 2026 |
| Jefferies | Initiated Coverage | Buy | $180.00 | Mar 10, 2026 |
| Needham | Maintained | Buy | $170.00 | Feb 23, 2026 |
| Barclays | Initiated Coverage | Equal-Weight | $155.00 | Feb 20, 2026 |
Frequently asked questions
What is the latest analyst rating on GILD?
On Aug 5, 2026, Needham maintained Gilead Sciences at Buy with a price target of $170.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.